Small Molecule Prefilled Syringes Market, By Type (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), By Material Type (Glass and Plastic & Polymer), By Application (Diabetes, Cancer, Opthalmology, Anap
Description
Prefilled syringes have several advantages over traditional vial packaging, including ease of use. Prefilled syringes obviate the need for the processes that are required before using a drug in a vial. It also helps to eliminate dosing errors because prefilled syringes contain the exact dose. Many pharmaceutical manufacturers overfill vials by up to 25% to ensure that the end user receives the correct dose. However, overfilling can result in errors that are virtually eliminated with prefilled syringes. With the introduction of more expensive biotech drugs, this is advantageous because it means less waste, particularly if some vaccines are in short supply or extremely expensive.
Market Dynamics
Market players are focused on product launches or approvals, which is expected to contribute to the growth of the global small molecule prefilled syringes market over the forecast period. For instance, in March 2018, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy.
Market players are focused on launching manufacturing capabilities for prefilled syringes. This is expected to drive the market growth over the forecast period. For instance, in July 2019, Terumo Corporation, based in Japan, announced the construction of an additional production facility for pre-filled syringes at its subsidiary Terumo Yamaguchi D&D.
Market players focused on product launches is expected to propel the growth of the global small molecule prefilled syringes market. For instance, in March 2020, Dr. Reddy's Laboratories Ltd., a leading multinational pharmaceutical company, announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) Injection USP in India.
Key features of the study:
Market Dynamics
Market players are focused on product launches or approvals, which is expected to contribute to the growth of the global small molecule prefilled syringes market over the forecast period. For instance, in March 2018, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy.
Market players are focused on launching manufacturing capabilities for prefilled syringes. This is expected to drive the market growth over the forecast period. For instance, in July 2019, Terumo Corporation, based in Japan, announced the construction of an additional production facility for pre-filled syringes at its subsidiary Terumo Yamaguchi D&D.
Market players focused on product launches is expected to propel the growth of the global small molecule prefilled syringes market. For instance, in March 2020, Dr. Reddy's Laboratories Ltd., a leading multinational pharmaceutical company, announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) Injection USP in India.
Key features of the study:
- This report provides an in-depth analysis of global small molecule prefilled syringes market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global small molecule prefilled syringes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Sanofi, Viatris Inc. (Mylan N.V.), AstraZeneca Plc, F. Hoffmann-La Roche AG (Genentech, Inc.), Sun Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, and McKesson Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global small molecule prefilled syringes market
- Global Small Molecule Prefilled Syringes Market, By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- Global Small Molecule Prefilled Syringes Market, By Material Type :
- Glass
- Plastic & Polymer
- Global Small Molecule Prefilled Syringes Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Small Molecule Prefilled Syringes Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Sanofi
- Viatris Inc. (Mylan N.V.)
- AstraZeneca Plc
- F. Hoffmann-La Roche AG (Genentech, Inc.)
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Dr. Reddy’s Laboratories Ltd.
- Teva Pharmaceutical Industries Ltd.
- Fresenius Kabi AG
- McKesson Corporation.
Table of Contents
276 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Material Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Market Trends
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’S Analysis
- Industry Trends
- Product Launches and Approvals
- 4. Global Small Molecule Prefilled Syringes Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Small Molecule Prefilled Syringes Market, By Type, 2020– 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Single-chamber Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Dual-chamber Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Customized Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- 6. Global Small Molecule Prefilled Syringes Market, By Material Type, 2020– 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Plastic & Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- 7. Global Small Molecule Prefilled Syringes Market, By Application, 2020 – 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Opthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Anaphylaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Rheumatoid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- Others (Thrombosis, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Segment Trends
- 8. Global Small Molecule Prefilled Syringes Market, By Distribution Channel, 2020 – 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
- 9. Global Small Molecule Prefilled Syringes Market, By Region, 2020 – 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- North America
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 –2032, (US$ Bn)
- Market Size and Forecast, andY-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 –2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 –2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020 –2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
- 10. Competitive Landscape
- Company Profiles
- BD
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cytiva
- Merck KGaA
- Gaplast
- Ascendia Pharmaceuticals
- Sanofi
- Viatris Inc. (Mylan N.V.)
- Pfizer Inc.
- Dr. Reddy’s Laboratories Ltd.
- Fresenius Kabi AG
- McKesson Corporation
- Analysts’ Views
- 11. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 42 market data tables and 30 figures on “Global Small Molecule Prefilled Syringes Market” – Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
